fbpx
  • Panels
    • ePlex Panels
      • Respiratory
      • Blood Culture
    • XT-8 Panels
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
    • XT-8 System
  • Company
    • The GenMark Story
    • Careers
      • Opportunities
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • Hepatitis C
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Your Long-Term Partner
  • Customer Resource Center
Select your region:
  • United States
SELECT YOUR REGION:
  • United States
| CONTACT US | CUSTOMER RESOURCE CENTER
GenMark
  • Panels
    • ePlex Panels
      • Respiratory
      • Blood Culture
    • XT-8 Panels
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
    • XT-8 System
  • Company
    • The GenMark Story
    • Careers
      • Opportunities
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • Hepatitis C
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Your Long-Term Partner
  • Customer Resource Center

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hepatitis C

In 2018, there were more than 50,000 new hepatitis C infections in the US and it is estimated that there are 2.4 million people currently living with hepatitis C.1  Most people with an active infection have no symptoms and 50% of people infected with hepatitis C will have a chronic infection.2   Chronic hepatitis C infection can lead to cirrhosis or liver cancer, though antivirals can cure 95% of people with hepatitis C infections.3  There is currently no vaccine available for hepatitis C.

 

Recent data suggest that over 40% of people with hepatitis C will resolve the infection on their own.4 Because symptoms are often not present until there is advanced liver damage, in 2020 the CDC updated guidance for hepatitis C screening for adults to reduce morbidity and mortality.  The new recommendations include screening of all adults over 18 years of age at least once in their lifetime and screening of all pregnant women during each pregnancy.4  These updates were in addition to existing recommendations which include periodic testing of people with ongoing risk factors, testing of healthcare workers after exposure to hepatitis C positive blood, and babies born to hepatitis C infected mothers and additional recommendations that can be found at https://www.cdc.gov/mmwr/volumes/69/rr/rr6902a1.htm.

Hepatitis C Genotyping

Once a patient is confirmed to have hepatitis C, a genotyping test may be performed to identify which hepatitis C virus genotype is present.  Many hepatitis C therapies are genotype specific and identification of which hepatitis C virus genotype a person has can be used by the doctor to determine the best antiviral regimen to prescribe.5

 

CDC recommends all adults get tested for hepatitis C. Click here to learn more


1. Centers for Disease Control and Prevention. Viral Hepatitis. https://www.cdc.gov/hepatitis/abc/index.htm (accessed December 2020)
2. Moon, J., and Bailey, J. Hepatitis C. Johns Hopkins ABX Guide. (last updated February 2019).
3. World Health Organization. Hepatitis C. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed December 2020).
4. Schillie, S., et al. CDC Recommendations for Hepatitis C Screening Among Adults – United States, 2020. Recommendations and Reports, April 10, 2020. 69(2);1–17.
5. HCV Guidance: Recommendations for Testing, managing, and treating Hepatitis C. Infectious Disease Society of America. https://www.hcvguidelines.org/ (accessed December 2020).

 

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, CA 92008

 

© Copyright 2022 GenMark Diagnostics, Inc.
All rights reserved.

 

 
 
 
 

Legal | Privacy Policy

 

 

This website uses cookies to improve your experience. Read More. You can opt-out if you wish. Change settingsACCEPT REJECT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Popup Button